Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryan Aleong

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Heart Rhythm|May 18, 2024
Development and validation of the Atri-Risk Conduction Index risk score to predict risk of atrial fibrillation after typical atrial flutter ablationAlex Grubb, Ryan Aleong, Michael A Rosenberg, et al.
European Journal of Heart Failure|December 11, 2012
Effect of bucindolol on heart failure outcomes and heart rate response in patients with reduced ejection fraction heart failure and atrial fibrillationDavid P Kao, Gordon Davis, Ryan Aleong, et al.
Circulation|October 31, 2007
Mutation in glycerol-3-phosphate dehydrogenase 1 like gene (GPD1-L) decreases cardiac Na+ current and causes inherited arrhythmiasBarry London, Michael Michalec, Haider Mehdi, et al.
Heart Rhythm O2|March 4, 2022
Dose-limiting, adverse event-associated bradycardia with β-blocker treatment of atrial fibrillation in the GENETIC-AF trialWilliam T Abraham, Jonathan P Piccini, Christopher Dufton, et al.
Circulation. Arrhythmia and Electrophysiology|July 16, 2021
Bucindolol Decreases Atrial Fibrillation Burden in Patients With Heart Failure and the <i>ADRB1</i> Arg389Arg GenotypeJonathan P Piccini, Christopher Dufton, Ian A Carroll, et al.
JACC. Heart Failure|May 3, 2019
Bucindolol for the Maintenance of Sinus Rhythm in a Genotype-Defined HF Population: The GENETIC-AF TrialJonathan P Piccini, William T Abraham, Christopher Dufton, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Heart Rhythm|May 18, 2024
Development and validation of the Atri-Risk Conduction Index risk score to predict risk of atrial fibrillation after typical atrial flutter ablationAlex Grubb, Ryan Aleong, Michael A Rosenberg, et al.
European Journal of Heart Failure|December 11, 2012
Effect of bucindolol on heart failure outcomes and heart rate response in patients with reduced ejection fraction heart failure and atrial fibrillationDavid P Kao, Gordon Davis, Ryan Aleong, et al.
Circulation|October 31, 2007
Mutation in glycerol-3-phosphate dehydrogenase 1 like gene (GPD1-L) decreases cardiac Na+ current and causes inherited arrhythmiasBarry London, Michael Michalec, Haider Mehdi, et al.
Heart Rhythm O2|March 4, 2022
Dose-limiting, adverse event-associated bradycardia with β-blocker treatment of atrial fibrillation in the GENETIC-AF trialWilliam T Abraham, Jonathan P Piccini, Christopher Dufton, et al.
Circulation. Arrhythmia and Electrophysiology|July 16, 2021
Bucindolol Decreases Atrial Fibrillation Burden in Patients With Heart Failure and the <i>ADRB1</i> Arg389Arg GenotypeJonathan P Piccini, Christopher Dufton, Ian A Carroll, et al.
JACC. Heart Failure|May 3, 2019
Bucindolol for the Maintenance of Sinus Rhythm in a Genotype-Defined HF Population: The GENETIC-AF TrialJonathan P Piccini, William T Abraham, Christopher Dufton, et al.
Pageof 2